• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Clinical, haematological and parasitological response to treatment of visceral leishmaniasis in Kenya. A study of 64 patients.

作者信息

Kager P A, Rees P H, Manguyu F M, Bhatt K M, Wellde B T, Hockmeyer W T, Lyerly W H

出版信息

Trop Geogr Med. 1984 Mar;36(1):21-35.

PMID:6328709
Abstract

Sixty four Kenyan patients with visceral leishmaniasis were treated with sodium stibogluconate (Pentostam) (40 patients) or various combinations of Pentostam and allopurinol (24 patients). Three patients, initially considered cured after Pentostam, relapsed but responded to further treatment. Sixty two were cured and two patients died. The treatment and the clinical, haematological and parasitological response to treatment are described in detail. If follow up is impossible or unlikely it is advised to continue treatment until parasitological cure is obtained. Prolonged courses of Pentostam, which were required in some patients, resulted in cures and apparently were non toxic. Consideration is to be given to extended treatment with Pentostam before more toxic drugs such as pentamidine and amphotericin B are given.

摘要

相似文献

1
Clinical, haematological and parasitological response to treatment of visceral leishmaniasis in Kenya. A study of 64 patients.
Trop Geogr Med. 1984 Mar;36(1):21-35.
2
Is one year follow-up justified in kala-azar post-treatment?黑热病治疗后进行一年的随访是否合理?
East Afr Med J. 1994 Jul;71(7):453-9.
3
Complications of kala azar and its treatment in Kenya.肯尼亚黑热病的并发症及其治疗
East Afr Med J. 1984 Feb;61(2):120-7.
4
Problems in the treatment of kala-azar: case report.黑热病治疗中的问题:病例报告
East Afr Med J. 1995 Jun;72(6):406-8.
5
Comparison of generic and proprietary sodium stibogluconate for the treatment of visceral leishmaniasis in Kenya.肯尼亚治疗内脏利什曼病的普通与专利葡萄糖酸锑钠对比研究。
Bull World Health Organ. 2001;79(5):388-93.
6
Clinical and serological follow-up in dogs with visceral leishmaniosis treated with allopurinol and sodium stibogluconate.用别嘌呤醇和葡萄糖酸锑钠治疗的内脏利什曼病犬的临床和血清学随访
Vet Parasitol. 2005 Mar 31;128(3-4):243-9. doi: 10.1016/j.vetpar.2004.12.002.
7
[Imported leishmaniasis of dogs: clinical aspects, diagnosis and therapy with Na stibogluconate (Pentostam)].[犬类输入性利什曼病:临床症状、诊断及使用葡糖酸锑钠(喷他脒)进行治疗]
Tierarztl Prax. 1987;15(3):305-10.
8
Visceral leishmaniasis unresponsive to antimonial drugs. III. Successful treatment using a combination of sodium stibogluconate plus allopurinol.
Trans R Soc Trop Med Hyg. 1985;79(5):715-8. doi: 10.1016/0035-9203(85)90200-7.
9
A comparative study of allopurinol and pentostam in the treatment of visceral leishmaniasis.别嘌呤醇与喷他脒治疗内脏利什曼病的对比研究。
Adv Exp Med Biol. 1986;195 Pt A:471-3. doi: 10.1007/978-1-4684-5104-7_78.
10
Treatment for visceral leishmaniasis.内脏利什曼病的治疗
J Assoc Physicians India. 1987 Sep;35(9):641-3.

引用本文的文献

1
Prognostic factors for mortality among patients with visceral leishmaniasis in East Africa: Systematic review and meta-analysis.东非内脏利什曼病患者死亡率的预后因素:系统评价和荟萃分析。
PLoS Negl Trop Dis. 2020 May 15;14(5):e0008319. doi: 10.1371/journal.pntd.0008319. eCollection 2020 May.
2
Experimental visceral leishmaniasis: role of trans-aconitic acid in combined chemotherapy.实验性内脏利什曼病:反乌头酸在联合化疗中的作用
Antimicrob Agents Chemother. 1993 Nov;37(11):2459-65. doi: 10.1128/AAC.37.11.2459.
3
Rationalisation of regimens of treatment of kala-azar with sodium stibogluconate in India: a randomised study.
印度葡萄糖酸锑钠治疗黑热病方案的合理化:一项随机研究。
Br Med J (Clin Res Ed). 1988 Jun 4;296(6636):1557-61. doi: 10.1136/bmj.296.6636.1557.